Short answer · Medically reviewed summary · Last updated: 2026-04-07
The ICD-10-CM code for Hereditary multiple exostoses is Q78.6, while the older ICD-9-CM classification system identified this condition under the code 756.4. These codes are essential for medical billing and tracking the clinical progression of Hereditary multiple exostoses within global health databases. What is the clinical significance of the ICD codes for Hereditary multiple exostoses? In the medical community, the ICD-10 code Q78.6 (Multiple congenital exostoses) serves as the standardized language used by clinicians to document the presence of multiple benign bone growths, known as osteochondromas, which characterize Hereditary multiple exostoses.
The ICD-10-CM code for Hereditary multiple exostoses is Q78.6, while the older ICD-9-CM classification system identified this condition under the code 756.4. These codes are essential for medical billing and tracking the clinical progression of Hereditary multiple exostoses within global health databases.
In the medical community, the ICD-10 code Q78.6 (Multiple congenital exostoses) serves as the standardized language used by clinicians to document the presence of multiple benign bone growths, known as osteochondromas, which characterize Hereditary multiple exostoses. Because this is a rare, lifelong genetic condition, using the correct diagnostic code is vital for ensuring that insurance providers and healthcare systems recognize the chronic nature of Hereditary multiple exostoses. Accurate coding allows for the longitudinal tracking of complications, such as limb length discrepancies or potential malignant transformation, which are critical areas of focus for the 266 members of our DiseaseMaps.org community living with this diagnosis.
Yes, Hereditary multiple exostoses is an autosomal dominant genetic disorder. This means that an individual only needs to inherit one mutated copy of the causative gene—typically EXT1 or EXT2—to manifest the condition. Because the inheritance pattern is autosomal dominant, there is a 50% chance that a parent with Hereditary multiple exostoses will pass the mutation to each of their children. Genetic counseling is highly recommended for families to understand the risks and the variability of clinical expression, as even family members with the same mutation can experience significantly different levels of skeletal involvement.
The hallmark of Hereditary multiple exostoses is the development of multiple bony outgrowths capped with cartilage near the growth plates of long bones. While the number and size of these exostoses vary widely, they frequently lead to specific musculoskeletal challenges:
Diagnosis is usually confirmed through a combination of clinical physical examination, radiographic imaging (X-rays, CT, or MRI), and genetic testing to identify mutations in the EXT1 or EXT2 genes. Management is multidisciplinary, often requiring a team consisting of orthopedic surgeons, physical therapists, and geneticists. For the 266 individuals within our DiseaseMaps.org network, management focuses on monitoring for rapid growth or pain, which may indicate a need for surgical intervention to excise painful exostoses or correct angular deformities.
Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.